Opana ER is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Oxymorphone Hydrochloride.
Product ID | 63629-4174_b0d683e0-ee2e-4a82-8ae5-fec301c8167b |
NDC | 63629-4174 |
Product Type | Human Prescription Drug |
Proprietary Name | Opana ER |
Generic Name | Oxymorphone Hydrochloride |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2010-12-31 |
Marketing Category | NDA / NDA |
Application Number | NDA021610 |
Labeler Name | Bryant Ranch Prepack |
Substance Name | OXYMORPHONE HYDROCHLORIDE |
Active Ingredient Strength | 20 mg/1 |
Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
DEA Schedule | CII |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2010-12-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021610 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-12-31 |
Inactivation Date | 2019-11-27 |
Marketing Category | NDA |
Application Number | NDA021610 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-09-15 |
Inactivation Date | 2019-11-27 |
Marketing Category | NDA |
Application Number | NDA021610 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-12-31 |
Inactivation Date | 2019-11-27 |
Marketing Category | NDA |
Application Number | NDA021610 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-12-31 |
Inactivation Date | 2019-11-27 |
Ingredient | Strength |
---|---|
OXYMORPHONE HYDROCHLORIDE | 20 mg/1 |
SPL SET ID: | 0ae0e103-5250-4745-8ae2-74fa47fbf973 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
21695-948 | OPANA ER | OPANA ER |
21695-949 | OPANA ER | OPANA ER |
35356-825 | Opana ER | Opana ER |
35356-848 | Opana ER | Opana ER |
35356-849 | Opana ER | Opana ER |
35356-820 | Opana ER | Opana ER |
63481-816 | Opana ER | Opana ER |
63481-817 | Opana ER | Opana ER |
63481-814 | Opana ER | Opana ER |
63481-815 | Opana ER | Opana ER |
63481-818 | Opana ER | Opana ER |
63481-812 | Opana ER | Opana ER |
63481-813 | Opana ER | Opana ER |
63629-4174 | Opana ER | Opana ER |
63629-4177 | OPANA ER | OPANA ER |
0054-0283 | Oxymorphone Hydrochloride | oxymorphone hydrochloride |
0054-0284 | Oxymorphone Hydrochloride | oxymorphone hydrochloride |
0115-1231 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1232 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1233 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1234 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1315 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1316 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1317 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() OPANA ER 85341864 4101723 Dead/Cancelled |
Endo Pharmaceuticals Inc. 2011-06-09 |